Low Field Magnetic Stimulation: Open Label Study.

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Mood Disorders, Anxiety

In brief

To assess the effects of daily LFMS treatments for those suffering from affective or anxiety symptoms. We hypothesize a reduction in affective and or anxiety symptoms after active treatment over the period of one week, with improvement through the following week.

Key facts

Study ID: NCT02542475
Run by: Mclean Hospital
People needed: 40
Starts: 2015-09-01
Expected to finish: 2020-08-01
Last updated by the study team: 2016-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Subjects will be accepted into the study upon written referral by a McLean clinician or outside psychiatrist.
Subjects will be men or women over the age of 18.
Subjects must have failed at least one FDA approved treatment before enrolling in this study.
Subjects must be capable of providing informed consent.
Subjects must have either a Hamilton Depression Rating Scale (HDRS) score > 14 indicating moderate depression or Hamilton Anxiety Rating Scale (HARS) score > 18 indicating moderate anxiety.

You may not qualify if…

Dangerous or active suicidal ideation.
Pregnant or planning on becoming pregnant.
Recent history (within 3 days) of ECT or TMS treatment.
Substance abuse (cannot meet DSM criteria for substance abuse, no significant drug abuse within last 3 months, no history of dependence in last year, no drug use within last month, other than marijuana use).
Current psychosis.
Contraindications for MRI: Presence of a pacemaker, neurostimulator, or metal in head or neck.
"Do Not Resuscitate" order in place (to avoid risk in the case of non-study-related accidents).

Where it is running

McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.